Key result
2017 ACC/AHA guidelines more than double estimated hypertension prevalence in Peru to ~32%.
Why the study?
The 2017 ACC/AHA hypertension guideline redefined hypertension thresholds, potentially increasing prevalence estimates and treatment eligibility, necessitating updated national estimates for Peru to inform public health planning.
Does the application of the 2017 ACC/AHA hypertension guidelines increase the estimated prevalence of hypertension compared to JNC7 guidelines in Peruvian adults?
Population
32,514 individuals aged 15 years and older from the nationally representative Demographic and Family Health Survey (ENDES) 2017 in Peru
Comparison
2017 ACC/AHA hypertension guidelines (SBP ≥130 mmHg or DBP ≥80 mmHg) vs JNC7 guidelines (SBP ≥140 mmHg or DBP ≥90 mmHg)
Design
Cross-sectional analytical study
Authors
Loading...
New thresholds may reclassify more adults as hypertensive; leaves open whether tighter targets improve outcomes in observational data.
Cross-Sectional (n=32,514)
Does the application of the 2017 ACC/AHA hypertension guidelines increase the estimated prevalence of hypertension compared to JNC7 guidelines in Peruvian adults?
Absolute Event Rate: 31.5% vs 13.6%
Adoption of the 2017 ACC/AHA hypertension guidelines in Peru would increase the estimated prevalence of hypertension from 13.6% to 31.5%, highlighting a major public health challenge given the high proportion of individuals lacking access to routine blood pressure measurements.
Hernández‐Vásquez et al. (2018) conducted a cross-sectional in Hypertension (n=32,514). 2017 ACC/AHA hypertension guidelines vs. JNC7 guidelines was evaluated on Prevalence of hypertension. Applying the 2017 ACC/AHA guidelines increased the estimated prevalence of hypertension in Peru to 31.5% compared to 13.6% under the previous JNC7 guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: